retatrutide injection needle size What is recommended for subcutaneous of 2mg in an adult? Retatrutide - “Triple G” |

Weight loss effects of GLP-1RAs Liraglutide (3.0 mg, Saxenda), a GLP-1RA that activates the GLP-1 receptor, was approved by the FDA in December 2014 for adult obesity treatment [38] and has recently shown efficacy in adolescents aged 12 to 18 years

Lemonaid Medical Team Quality care, patient-first providers Youll always feel seen and heard with our team of U.S.-licensed medical providers

Weekly measurements Weigh yourself once per week, same day, same time, same conditions (morning, after using the bathroom, before eating)

The oral version was previously available for diabetes management (under the brand name Rybelsus), but this new FDA approval specifically authorizes a high-dose oral formulation for chronic weight management

Diabetes, Obesity and Metabolism (NLM) .Read source (2025)